Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 10, 2013, Pages 2461-2468

  Lo, Hsin Yi ^a   Ho, Tin Yun ^a   Lin, Chingju ^a   Li, Chia Cheng ^a   Hsiang, Chien Yun ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

diabetes mellitus; inhibitor against trypsin; insulin receptor; Momordica charantia

Indexed keywords

ALTERNATIVE THERAPY; DIABETES MELLITUS; DOSE-DEPENDENT MANNER; HYPOGLYCEMIC EFFECT; INHIBITOR AGAINST TRYPSIN; INSULIN RECEPTORS; MOMORDICA CHARANTIA; RECEPTOR-BINDING ASSAYS;

GLUCOSE; MAMMALS; PROTEINS; SIGNALING; TISSUE;

INSULIN;

ANTIDIABETIC AGENT; INSULIN; INSULIN RECEPTOR; PLANT EXTRACT;

ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; CONFERENCE PAPER; DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MOMORDICA CHARANTIA; MOUSE; MOUSE MUTANT; PHYTOTHERAPY; PLANT SEED; PROTEIN BINDING; PROTEOMICS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; MICE, INBRED BALB C; MICE, OBESE; MOMORDICA CHARANTIA; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN BINDING; PROTEOMICS; RECEPTOR, INSULIN; SEEDS;

EID: 84874994166     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf3042402     Document Type: Conference Paper

References (41)

1. Leung, L.; Birtwhistle, R.; Kotecha, J.; Hannah, S.; Cuthbertson, S. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review Br. J. Nutr. 2009, 102, 1703-1708
2. Chaturvedi, P. Antidiabetic potentials of Momordica charantia: multiple mechanisms behind the effects J. Med. Food 2012, 15, 101-107
3. Broadhurst, C. L.; Polansky, M. M.; Anderson, R. A. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro J. Agric. Food Chem. 2000, 48, 849-852
4. Singh, J.; Cumming, E.; Manoharan, G.; Kalasz, H.; Adeghate, E. Medicinal chemistry of the anti-diabetic effects of Momordica charantia: active constituents and modes of actions Open Med. Chem. J. 2011, 5, 70-77
5. Harinantenaina, L.; Tanaka, M.; Takaoka, S.; Oda, M.; Mogami, O.; Uchida, M.; Asakawa, Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds Chem. Pharm. Bull. 2006, 54, 1017-1021
6. Tan, M. J.; Ye, J. M.; Turner, N.; Honen-Behrens, C.; Ke, C. Q.; Tang, C. P.; Chen, T.; Weiss, H. C.; Gesing, E. R.; Rowland, A.; James, D. E.; Ye, Y. Antidiabetic activities of triterpenoids isolated from bitter melon associated with the activation of AMPK pathway Chem. Biol. 2008, 15, 263-273
7. Keller, A. C.; Ma, J.; Kavalier, A.; He, K.; Brillantes, A. M.; Kennelly, E. J. Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro Phytomedicine 2011, 19, 32-37
8. Matsuda, H.; Murakami, T.; Shimada, H.; Matsumura, N.; Yoshikawa, M.; Yamahara, J. Inhibitory mechanisms of oleanolic acid 3- O -monodesmosides on glucose absorption in rats Biol. Pharm. Bull. 1997, 20, 717-719
9. Matsuda, H.; Li, Y.; Murakami, T.; Matsumura, N.; Yamahara, J.; Yoshikawa, M. Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity Chem. Pharm. Bull. 1998, 46, 1399-1403
10. Horax, R.; Hettiarachchy, N.; Over, K.; Chen, P.; Gbur, E. Extraction, fractionation and characterization of bitter melon seed proteins J. Agric. Food Chem. 2010, 58, 1892-1897
11. Khanna, P.; Jain, S. C.; Panagariya, A.; Dixit, V. P. Hypoglycemic activity of polypeptide-p from a plant source J. Nat. Prod. 1981, 44, 648-655
12. Liu, S. X.; Fu, Z. P.; Mu, R. M.; Hu, Z. B.; Wang, F. J.; Wang, X. R. Expression and characterization of Momordica chanrantia anti-hyperglycaemic peptide in Escherichia coli Mol. Biol. Rep. 2010, 37, 1781-1786
13. Rajasekhar, M. D.; Badri, K. R.; Vinay Kumar, K.; Kassetti, R. B.; Fatima, S. S.; Sampath Kumar, M. T.; Appa Rao, C. Isolation and characterization of a novel antihyperglycemic protein from the fruits of Momordica cymbalaria J. Ethnopharmacol. 2010, 128, 58-62
14. Muurling, M.; Mensink, R. P.; Pijl, H.; Romijn, J. A.; Havekes, L. M.; Voshol, P. J. Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob / ob mice Metabolism 2003, 52, 1078-1083
15. Cheng, W. Y.; Lien, J. C.; Hsiang, C. Y.; Wu, S. L.; Li, C. C.; Lo, H. Y.; Chen, J. C.; Chiang, S. Y.; Liang, J. A.; Ho, T. Y. Comprehensive evaluation of a novel nuclear factor-κB inhibitor, quinoclamine, by transcriptomic analysis Br. J. Pharmacol. 2009, 157, 746-756
16. Hsiang, C. Y.; Chen, Y. S.; Ho, T. Y. Nuclear factor-κB bioluminescence imaging-guided transcriptomic analysis for the assessment of hoist-biomaterial interaction in vivo Biomaterials 2009, 30, 3042-3049
17. Smyth, G. K. Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor; Gentleman, R.; Carey, V.; Dudoit, S.; Irizarry, R.; Huber, W., Eds.; Springer; New York, 2005; pp 397-420.
18. Pessin, J. E.; Saltiel, A. R. Signaling pathways in insulin action: molecular targets of insulin resistance J. Clin Invest. 2000, 106, 165-169
19. Saltiel, A. R.; Kahn, C. R. Insulin signalling and the regulation of glucose and lipid metabolism Nature 2001, 414, 799-806
20. Hirosawa, M.; Hoshida, M.; Ishikawa, M.; Toya, T. MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming Comput. Appl. Biosci. 1993, 9, 161-167
21. Schneidman-Duhovny, D.; Inbar, Y.; Nussinov, R.; Wolfson, H. J. PatchDock and SymmDock: servers for rigid and symmetric docking Nucleic Acids Res. 2005, 33, W363-W367
22. Nadiv, O.; Shinitzky, M.; Manu, H.; Hecht, D.; Roberts, C. T., Jr.; LeRoith, D.; Zick, Y. Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats Biochem. J. 1994, 298, 443-450
23. Scartezzini, P.; Speroni, E. Review on some plants of Indian traditional medicine with antioxidant activity J. Ethnopharmacol. 2000, 71, 23-43
24. Puri, M.; Kaur, I.; Kanwar, R. K.; Gupta, R. C.; Chauhan, A.; Kanwar, J. R. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy Curr. Mol. Med. 2009, 9, 1080-1094
25. McKern, N. M.; Lawrence, M. C.; Streltsov, V. A.; Lou, M. Z.; Adams, T. E.; Lovrecz, G. O.; Elleman, T. C.; Richards, K. M.; Bentley, J. D.; Pilling, P. A.; Hoyne, P. A.; Cartledge, K. A.; Pham, T. M.; Lewis, J. L.; Sankovich, S. E.; Stoichevska, V.; Da Silva, E.; Robinson, C. P.; Frenkel, M. J.; Sparrow, L. G.; Fernley, R. T.; Epa, V. C.; Ward, C. W. Structure of the insulin receptor ectodomain reveals a folded-over conformation Nature 2006, 443, 218-221
26. Basch, E.; Gabardi, S.; Ulbricht, C. Bitter melon (Momordica charantia): a review of efficacy and safety Am. J. Health Syst. Pharm. 2003, 60, 356-359
27. Krawinkel, M. B.; Keding, G. B. Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia Nutr. Rev. 2006, 64, 331-337
28. Hsu, C.; Hsieh, C. L.; Kuo, Y. H.; Huang, C. J. Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia J. Agric. Food Chem. 2011, 59, 4553-4561
29. Wang, X.; Sun, W.; Cao, J.; Qu, H.; Bi, X.; Zhao, Y. Structures of new triterpenoids and cytotoxicity activities of the isolated major compounds from the fruit of Momordica charantia L J. Agric. Food Chem. 2012, 60, 3927-3933
30. Yibchok-anun, S.; Adisakwattana, S.; Yao, C. Y.; Sangvanich, P.; Roengsumran, S.; Hsu, W. H. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities Biol. Pharm. Bull. 2006, 29, 1126-1131
31. Shibib, B. A.; Khan, L. A.; Rahman, R. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase Biochem. J. 1993, 292, 267-270
32. Ben, W. C.; Roffey, B. W.; Atwal, A. S.; Johns, T.; Kubow, S. Water extracts from Momordica charantia increase glucose uptake and adiponectin secretion in 3T3-L1 adipose cells J. Ethnopharmacol. 2007, 112, 77-84
33. Cheng, H. L.; Huang, H. K.; Chang, C. I.; Tsai, C. P.; Chou, C. H. A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase J. Agric. Food Chem. 2008, 56, 6835-6843
34. Klomann, S. D.; Mueller, A. S.; Pallauf, J.; Krawinkel, M. B. Antidiabetic effects of bitter gourd extracts in insulin-resistant db / db mice Br. J. Nutr. 2010, 104, 1613-1620
35. Kumar, R.; Balaji, S.; Uma, T. S.; Sehgal, P. K. Fruit extracts of Momordica charantia potentiate glucose uptake and up-regulate Glut-4, PPAR gamma and PI3K J. Ethnopharmacol. 2009, 126, 533-537
36. Wang, B. L.; Zhang, W. J.; Zhao, J.; Wang, F. J.; Fan, L. Q.; Wu, Y. X.; Hu, Z. B. Gene cloning and expression of a novel hypoglycaemic peptide from Momordica charantia J. Sci. Food Agric. 2011, 91, 2443-2448
37. Wang, F. J.; Song, H. L.; Wang, X. M.; Zhang, W. J.; Wang, B. L.; Zhao, J.; Hu, Z. B. Tandem multimer expression and preparation of hypoglycemic peptide MC6 from Momordica charantia in Escherichia coli Appl. Biochem. Biotechnol. 2012, 166, 612-619
38. Miura, S.; Funatsu, G. Isolation and amino acid sequences of two trypsin inhibitors from the seeds of bitter gourd (Momordica charantia) Biosci., Biotechnol., Biochem. 1995, 59, 469-473
39. Forgue-Lafitte, M. E.; Marescot, M. R.; Chamblier, M. C.; Rosselin, G. Evidence for the presence of insulin binding sites in isolated rat intestinal epithelial cells Diabetologia 1980, 19, 373-378
40. Camenisch, G.; Alsenz, J.; Van de Waterbeemd, H.; Folkers, G. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight Eur. J. Pharm. Sci. 1998, 6, 317-324
41. Bastian, S. E.; Walton, P. E.; Ballard, F. J.; Belford, D. A. Transport of IGF-I across epithelial cell monolayers J. Endocrinol. 1999, 162, 361-369